12-week coffee compound study shows promising results for weight and fat reduction in at-risk individuals

Cafestol may aid in reducing body weight and visceral fat, but its impact on insulin sensitivity and glucose tolerance remains limited, according to the study.

Cancer biotech Intensity Therapeutics looks to pull in $16M+ IPO

Cancer biotech Intensity Therapeutics launched an IPO as it aims to advance a therapy being tested in sarcoma and breast cancer. The Connecticut biotech announced

July 1, 2023

Pharmalittle: FTC suspends challenge to Amgen deal for Horizon; AstraZeneca is latest to challenge Medicare drug negotiations

Good morning, everyone, and nice to see you again after a week-long respite, during which we tended to all sorts of sundry matters and hung

August 28, 2023

Zerva acquires Acer Therapeutics to bolster rare disease portfolio – Pharmaceutical Technology

The news caused Acer’s stock to skyrocket by 140% when the markets opened on 31 August. Image Credit: 3rdtimeluckystudio / Shutterstock. Zerva Therapeutics, formerly KemPharm,

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.